Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, OH 43205, USA.
Clin Infect Dis. 2013 Jan;56(1):58-64. doi: 10.1093/cid/cis807. Epub 2012 Sep 25.
Human adenovirus (HAdV) infection mimics Kawasaki disease (KD) but can also be detected in KD patients. Evidence suggests that HAdV-C species can persist in pediatric adenoids and/or tonsils. We sought to determine (1) the frequency of HAdV detection by real-time polymerase chain reaction in KD patients, (2) the differences in HAdV semiquantitative nasopharyngeal viral loads between KD patients with detectable HAdV vs those with HAdV disease, and (3) whether nasopharyngeal HAdV-C shedding is occurring in KD.
From August 2009 through April 2011, HAdV-positive patients were identified in 1 of the following groups: group I, complete or incomplete KD as defined by the American Heart Association (AHA); group II, treated for incomplete KD but not fulfilling AHA criteria; and group III, otherwise healthy children with some KD-like features ultimately diagnosed with HAdV disease.
Among 77 KD patients diagnosed, 8.8% (5/57) of group I and 25% (5/20) of group II KD patients had HAdV detected. Viral loads were significantly lower in group I (n = 5) vs group III (n = 26; P = .034). Of the 13 specimens available for HAdV typing, 7 of 7 group III and 1 of 3 group II specimens were determined to be HAdV-B using viral culture. The remaining 5 KD samples were unable to be cultured and molecular typing showed either HAdV-C (n = 3) or were nontypeable (n = 2).
In KD, molecular-based HAdV detection is not uncommon, may represent persistence of HAdV-C, and should be interpreted with caution. Together, quantitative polymerase chain reaction and HAdV typing may aid in distinguishing HAdV disease mimicking KD from KD with concomitant HAdV detection.
人类腺病毒(HAdV)感染类似于川崎病(KD),但也可在 KD 患者中检测到。有证据表明,HAdV-C 种可在儿科腺样体和/或扁桃体中持续存在。我们试图确定(1)通过实时聚合酶链反应在 KD 患者中检测到 HAdV 的频率,(2)在 KD 患者中检测到 HAdV 与 HAdV 疾病之间 HAdV 半定量鼻咽病毒载量的差异,以及(3)在 KD 中是否存在鼻咽 HAdV-C 脱落。
从 2009 年 8 月至 2011 年 4 月,通过以下 1 组确定 HAdV 阳性患者:组 I,美国心脏协会(AHA)定义的完全或不完全 KD;组 II,治疗不完全 KD 但不符合 AHA 标准;和组 III,最终诊断为 HAdV 疾病的其他具有某些 KD 样特征的健康儿童。
在所诊断的 77 例 KD 患者中,组 I(5/57)和组 II KD 患者(5/20)中分别有 8.8%(5/57)和 25%(5/20)检测到 HAdV。组 I(n = 5)与组 III(n = 26;P =.034)的病毒载量明显较低。在 13 个可用于 HAdV 分型的标本中,7 个组 III 标本和 3 个组 II 标本确定为 HAdV-B 使用病毒培养。其余 5 个 KD 样本无法进行培养,分子分型显示 HAdV-C(n = 3)或无法分型(n = 2)。
在 KD 中,基于分子的 HAdV 检测并不少见,可能代表 HAdV-C 的持续存在,应谨慎解释。定量聚合酶链反应和 HAdV 分型的联合使用可能有助于区分模仿 KD 的 HAdV 疾病与并发 HAdV 检测的 KD。